Skip to main content

Table 4 Appraisal of the patient decision aid (n = 69)

From: Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs

  Mostly disagree
(1 point)
Neutral
(3 points)
Mostly agree
(5 points)
Mean ± SD
Subjective impact of the PtDA
 I learned a lot from the PtDA 11 % 17 % 71 %  
 The PtDA contained new information 7 % 23 % 70 %  
 The PtDA helped me to gain insight into my preferences, worries and questions 9 % 22 % 70 %  
 The PtDA helped me in making a decision about medication 11 % 18 % 70 %  
 The PtDA helped me in discussing my preferences, worries and questions with my rheumatologist 11 % 28 % 60 %  
Total impact     3.8 ± 0.9
Perceived usefulness
 The PtDA in general was useful 7 % 5 % 88 %  
 Reading the general information was useful 2 % 5 % 94 %  
 The specific information about DMARDs was useful 4 % 3 % 94 %  
 Comparing DMARDs was useful 4 % 8 % 89 %  
 Making notes in the digital notebook was useful 22 % 51 % 28 %  
 The exercises about preferences and worries were useful 11 % 29 % 59 %  
 The list of frequently asked questions was useful 12 % 32 % 56 %  
Total usefulness     4.0 ± 0.7
Perceived ease of use
 The website is easy to use 5 % 3 % 92 %  
 The information is easy to understand 2 % 6 % 92 %  
 The time the PtDA takes to finish is acceptable 5 % 5 % 90 %  
 The structure of the website is logical 10 % 11 % 79 %  
Total ease of use     4.5 ± 0.8
Attractiveness
 The colour of the website is pleasant 2 % 17 % 81 %  
 The font on the website is pleasant 4 % 9 % 87 %  
Total attractiveness     4.4 ± 0.9
Attitude towards future use
 I would use the PtDA again in the future 5 % 3 % 91 %  
 I would recommend the PtDA to others 2 % 7 % 89 %  
Total attitude     4.6 ± 0.9
Overall grade regarding the quality of the PtDA (range 0–10)    7.7 ± 0.9
  1. Percentages do not include missing cases. PtDA patient decision aid, DMARD disease modifying anti-rheumatic drug